Phagos

While most people have never heard of phages, they've been quietly keeping our planet in balance for billions of years. Every day, phages: 🌊 Keep ocean bacteria in check 🌱 Maintain soil health 🐄 Live peacefully in animal and human guts 🧬 Evolve to stay effective against bacteria Here's to scientists everywhere making phage therapy a reality. Happy #WorldPhageDay!

We ran along the Seine, walked to the office, and took forest strolls for the Treely Walking Challenge 👣 339,400 steps total 🌳 214 square meters of trees planted Great job to everyone who participated in the challenge!

We're thrilled to share that Phagos has secured a €25M Series A fundraising. But this milestone isn't just about funding. It's about breaking barriers. We've achieved the world's first regulatory authorization for personalized phage veterinary drugs – a breakthrough not just for us but the entire field of phage therapy. Personalized medicine is the future, phage therapy is ready to scale, and we can outsmart bacterial evolution itself. We know the crisis: - Bacterial disease is the 2nd leading cause of human mortality - 1 in 3 livestock antibiotics no longer work - Antimicrobial resistance (AMR) threatens $100 trillion in economic losses The answer is AI-powered phage therapy that designs and continuously updates treatments to stay effective indefinitely. With this new chapter, we will: 🌍 Scale veterinary deployments globally 🤖 Advance our patented AI discovery platform 👥 Grow our science, engineering, and business teams 🏥 Prepare to transform human health next Thank you to all our Series A investors for your trust and support Capagro, Hoxton Ventures, CapHorn, Demeter Acurio Ventures, Citizen Capital, Entrepreneurs First, Founders Capital, and STATION F. Read more at: https://lnkd.in/efFV4Mtz Join our mission at : https://lnkd.in/e5vu9ETS

So no, we don’t want to see antibiotics fail. But, we do have nature's backup plan ready. No farmer wants to see antibiotics fail. And they definitely don't want to stand by helplessly. That’s why they’re turning to phage therapy. Phages are nature’s way of controlling bacterial populations and the most abundant biological entity on earth Using our massive phage collection we can design a new medicine in only 2 months (and soon, in a matter of days). That’s 100x faster than developing a new antibiotic. And the best part? The way phages work is universal across all life forms. Salmonella in chickens? Staph infections in humans? E. coli in food factories? → Phage therapy can handle that

How do you teach AI to read the language of life itself? That's exactly what Andrea Di Gioacchino and András Asbóth tackled when they sat down for a chat on the AWS Developer Podcast Go behind-the-scenes of how they built our proprietary Gen AI model capable of predicting phage-bacterial interactions, which allows us to design personalized bacterial treatments in only 2 months. They talk about the terabytes of genetic data the project required, the technical challenges they faced, and what this could mean for the future of healthcare. Listen at: https://lnkd.in/eWySF6gx #phagetherapy #GenAI #biotech

Every 25 seconds, someone dies from an infection that antibiotics can no longer cure. This is the reality of antimicrobial resistance (AMR) – and it's accelerating faster than we're developing new antibiotics. While we've been struggling with this crisis, nature has been quietly offering a solution for 3 billion years. Meet bacteriophages, or simply phages. These microscopic entities are capable of eliminating pathogenic bacteria while being: ✅ Highly targeted: 1 phage effective against 1 bacterial strain ✅ Naturally present in the environment: estimated 10^31 on earth ✅ Safe: harmless to human cells ✅ Adaptive: they evolve in order to stay effective against bacteria The question isn't whether phages will transform medicine – it's how quickly we can scale it to save lives. Swipe through to see the full scope of the #AMR crisis and why phages represent hope → #AntibioticResistance #PhageTherapy

We’re #hiring. See our latest openings 👇 ☁️ CloudOps Engineer 🐓 Field Technician 🧪 Lab assistant 🧬 Research Lab Intern Apply on https://lnkd.in/e5vu9ETS

We’re #hiring. See our latest openings 👇 ☁️ CloudOps Engineer 🐓 Field Technician 🧪 Lab assistant 🧬 Research Lab Intern Apply on https://lnkd.in/e5vu9ETS

What if we could predict bacterial treatment success before even starting? Andrea Di Gioacchino, our Head of Data, just presented CAPHARD at [BC]2, the Basel Computational Biology Conference. CAPHARD is our patented transformer-based #AI model. It’s able to predict how effective a phage will be against specific bacterial strains using their complete genetic codes. We’re honored to be part of this amazing cohort of researchers across infectious diseases, cancer research, clinical data science, and protein design SIB Swiss Institute of Bioinformatics #ArtificialIntelligence #Biotechnology #BC2Basel

🎉 We secured a grant from EuroHPC Joint Undertaking (EuroHPC JU) bringing us 200,000 GPU hours of computing power as part of their effort to support high-impact, high-gain innovative research. This grant, worth nearly $1 million, accelerates our ability to use #deeplearning to make precision phage therapy scalable. And it includes access to the Leonardo pre-exascale supercomputer in Italy. More computing power = faster breakthroughs = deploying personalized phage treatments in the field sooner. Thank you to EuroHPCJU for your continued support in our innovation roadmap.